Strategic Performance and Market Positioning

• Management attributed a slight book value decline to mark-to-market adjustments on preferred stock and warrants, while highlighting that cash available for distribution (CAD) grew to $0.58 per share.

• The company successfully refinanced $180 million in senior unsecured notes with a $242 million total return swap (TRS) facility, removing a major liability overhang and providing $45 million in incremental deployment capacity.

• A strategic re-REMIC execution of a CMBS B-Piece generated $0.46 per share of book value appreciation and is expected to drive $0.34 per share of annual CAD accretion.

• Residential strategy is focused on a 'supply trough' thesis, with management noting that multifamily construction starts are 70% below their 2022 peak, which should support collateral values in 2026 and 2027.

• Life science exposure is concentrated in 'infrastructure-grade' assets like the Alewife project, which reached 71% occupancy and is benefiting from a demand funnel widened by AI companies requiring high power density and cooling.

• The company is piloting and deploying AI across its platform, targeting a 50% reduction in underwriting cycle times and implementing 'always-on' surveillance for its 92-plus investments as part of a roadmap for full optimization throughout 2027.

Outlook and Strategic Initiatives

• For Q1 2026, earnings available for distribution was $0.43 per diluted share, while cash available for distribution was $0.58 per diluted share.

• Management expects the residential sector to improve meaningfully in 2026 and 2027 as national multifamily deliveries are forecast to fall approximately 49% from 2025 levels.

• The investment pipeline includes $190 million across 11 active deals and $275 million in structured product opportunities, with returns expected to exceed the cost of the new TRS facility.

• The company intends to continue opportunistic stock buybacks, viewing the current discount to the $18.96 book value as an accretive use of capital alongside pipeline funding.

• AI integration is scheduled to scale across the full portfolio by Q4 2026, with full optimization of predictive credit models and automated reporting expected throughout 2027.

Risk Factors and Structural Adjustments

• The transition from fixed-rate senior notes to a floating-rate TRS facility (SOFR plus 375 bps) aligns the liability structure with the floating-rate asset base but introduces sensitivity to the SOFR curve.

• Life science concentration in Massachusetts (28.7%) and California (5.2%) remains a key focal point, though management argues these are 'first-to-fill' elite educational districts.

• Self-storage assets are currently in a 'cyclical bottoming process,' with management expecting flat revenue and slight NOI declines for the full year across the industry.

• The portfolio maintains a low net debt-to-equity ratio of below 1x, which management cites as a primary differentiator in the commercial mortgage REIT sector.